Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Circulating microRNA as biomarkers for predicting cladribine response in multiple sclerosis
Related
- Circulating biomarkers reflect distinct quantitative CT-defined features of systemic sclerosis-associated interstitial lung disease
- Maternal Circulating Angiogenic Biomarkers for Predicting Fetal Growth Restriction and Small-for-Gestational-Age Birth Without Preeclampsia
- The Impact of Cladribine Tablets on Cognition Over One Year in Patients With Multiple Sclerosis: A Preliminary Study.
- Long-Term Disease Control Following Completion of Cladribine Treatment in Multiple Sclerosis: Extended Follow-Up of the CladStop Cohort.
- Dysregulated microRNA–mRNA networks in SOD1G93A skeletal muscle reveal metabolic impairments in amyotrophic lateral sclerosis
BibTeX
@article{vigiser2026circulating,
title = {{Circulating microRNA as biomarkers for predicting cladribine response in multiple sclerosis}},
author = {Ifat Vigiser and Yoav Zeevi and Yoav Piura and Hadar Kolb and Maya Golan and Arnon Karni and Keren Regev},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74505-4},
url = {https://www.nature.com/articles/s41598-026-74505-4},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Circulating microRNA as biomarkers for predicting cladribine response in multiple sclerosis
AU - Ifat Vigiser
AU - Yoav Zeevi
AU - Yoav Piura
AU - Hadar Kolb
AU - Maya Golan
AU - Arnon Karni
AU - Keren Regev
PY - 2026
DA - 2026/10/05
JO - Scientific Reports
DO - 10.1038/s41598-026-74505-4
UR - https://www.nature.com/articles/s41598-026-74505-4
SN - 2045-2322
ER -